Vectors used to create hybrid constant regions

Details for Australian Patent Application No. 2004217433 (hide)

Owner Alexion Pharmaceuticals, Inc.

Inventors Bowdish, Katherine S.; Frederickson, Shana; Maruyama, Toshiaki

Agent Shelston IP

Pub. Number AU-A-2004217433

PCT Pub. Number WO2004/078937

Priority 60/451,820 04.03.03 US

Filing date 4 March 2004

Wipo publication date 16 September 2004

International Classifications

C07K 016/00 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

22 September 2005 PCT application entered the National Phase

  PCT publication WO2004/078937 Priority application(s): WO2004/078937

1 October 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004217434-Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof

2004217430-Security label and method for safeguarding objects